Intravenous Immunoglobulin for Maintenance Treatment of Multifocal Motor Neuropathy: A Multicenter, Open-Label, 52-Week Phase 3 Trial

Journal of the Peripheral Nervous System - United Kingdom
doi 10.1111/jns.12268